Biologics for Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: a Change Management Approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on Biologics in Rhinology

Overview

Journal Acta Otorhinolaryngol Ital

Specialty Otorhinolaryngology

Date 2021 Jul 23

PMID 34297014

Citations 34

Authors

Eugenio De Corso

Gianluca Bellocchi

Michele De Benedetto

Nicola Lombardo

Alberto Macchi

Luca Malvezzi

Gaetano Motta

Fabio Pagella

Claudio Vicini

Desiderio Passali

Affiliations

Soon will be listed here.

Citing Articles

Pilot Study on the Efficacy of a Novel Questionnaire for Assessing Psychological Health in Patients with Chronic Rhinosinusitis with Nasal Polyps Treated with Biologics.

Masieri S, Cavaliere C, Loperfido A, Begvarfaj E, Ciofalo A, Primerano F Healthcare (Basel). 2025; 13(4).

PMID: 39997308 PMC: 11855081. DOI: 10.3390/healthcare13040433.

Effect of Dupilumab on Radiological Remission in Patients with Chronic Rhinosinusitis with Nasal Polyp: A One Step Forward Toward Clinical Remission.

Al-Ahmad M, Ali A, Dawood H, Beshreda G J Asthma Allergy. 2024; 17:1027-1040.

PMID: 39464420 PMC: 11505379. DOI: 10.2147/JAA.S478040.

Assessing the Use of Patient-Reported Outcome Measures in the Routine Clinical Care of Chronic Rhinosinusitis Patients: A Canadian Perspective.

Kim H, Lee D, Shin D, Horton G, Gignac M, Lee J J Otolaryngol Head Neck Surg. 2024; 53:19160216241288806.

PMID: 39415404 PMC: 11487533. DOI: 10.1177/19160216241288806.

Changes in weight secondary to improved odor perception in chronic rhinosinusitis with nasal polyps' patients treated with Dupilumab.

Rosso C, De Corso E, Urbanelli A, Fadda G, Saibene A, Ferella F Eur Arch Otorhinolaryngol. 2024; 282(1):251-256.

PMID: 39404880 PMC: 11735516. DOI: 10.1007/s00405-024-09021-0.

Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients.

Dominguez-Sosa M, Cabrera-Ramirez M, Marrero-Ramos M, Davila-Quintana D, Cabrera-Lopez C, Cuervo H Ann Med. 2024; 56(1):2411018.

PMID: 39364704 PMC: 11457478. DOI: 10.1080/07853890.2024.2411018.

References

Whittington M, McQueen R, Ollendorf D, Tice J, Chapman R, Pearson S . Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis. Ann Allergy Asthma Immunol. 2016; 118(2):220-225. DOI: 10.1016/j.anai.2016.10.028. View

Tice J, Campbell J, Synnott P, Walsh J, Kumar V, Whittington M . The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma. J Manag Care Spec Pharm. 2019; 25(5):510-514. PMC: 10397880. DOI: 10.18553/jmcp.2019.25.5.510. View

Anderson 3rd W, Szefler S . Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic?. Ann Allergy Asthma Immunol. 2019; 122(4):367-372. DOI: 10.1016/j.anai.2019.01.018. View

De Corso E, Baroni S, Romitelli F, Luca L, Di Nardo W, Passali G . Nasal lavage CCL24 levels correlate with eosinophils trafficking and symptoms in chronic sino-nasal eosinophilic inflammation. Rhinology. 2011; 49(2):174-9. DOI: 10.4193/Rhino10.133. View

Hopkins C, Gillett S, Slack R, Lund V, Browne J . Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009; 34(5):447-54. DOI: 10.1111/j.1749-4486.2009.01995.x. View

Posteraro B, Scarano E, La Sorda M, Torelli R, De Corso E, Mule A . Eosinophilic fungal rhinosinusitis due to the unusual pathogen Curvularia inaequalis. Mycoses. 2009; 53(1):84-8. DOI: 10.1111/j.1439-0507.2008.01671.x. View

Bachert C, Mannent L, Naclerio R, Mullol J, Ferguson B, Gevaert P . Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. JAMA. 2016; 315(5):469-79. DOI: 10.1001/jama.2015.19330. View

Schleimer R . Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. Annu Rev Pathol. 2016; 12:331-357. PMC: 5514544. DOI: 10.1146/annurev-pathol-052016-100401. View

Bhattacharyya N, Villeneuve S, Joish V, Amand C, Mannent L, Amin N . Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope. 2019; 129(9):1969-1975. PMC: 6767455. DOI: 10.1002/lary.27852. View

10.

Lund V, Kennedy D . Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol Suppl. 1995; 167:17-21. View

11.

De Corso E, Baroni S, Lucidi D, Battista M, Romanello M, Autilio C . Nasal lavage levels of granulocyte-macrophage colony-stimulating factor and chronic nasal hypereosinophilia. Int Forum Allergy Rhinol. 2015; 5(6):557-62. DOI: 10.1002/alr.21519. View

12.

Tversky J, Lane A, Azar A . Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial. Clin Exp Allergy. 2021; 51(6):836-844. DOI: 10.1111/cea.13852. View

13.

Bachert C, Gevaert P, Holtappels G, JOHANSSON S, Van Cauwenberge P . Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001; 107(4):607-14. DOI: 10.1067/mai.2001.112374. View

14.

Gevaert P, Omachi T, Corren J, Mullol J, Han J, Lee S . Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020; 146(3):595-605. DOI: 10.1016/j.jaci.2020.05.032. View

15.

Lam J, Hay J, Salcedo J, Kenyon N . A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma. J Asthma. 2018; 56(8):872-881. DOI: 10.1080/02770903.2018.1500584. View

16.

Hopkins C, Hettige R, Soni-Jaiswal A, Lakhani R, Carrie S, Cervin A . CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis. Rhinology. 2018; 56(1):22-32. DOI: 10.4193/Rhin17.247. View

17.

Chowdhury N, Mace J, Smith T, Rudmik L . What drives productivity loss in chronic rhinosinusitis? A SNOT-22 subdomain analysis. Laryngoscope. 2017; 128(1):23-30. PMC: 5723565. DOI: 10.1002/lary.26723. View

18.

Bourdin A, Adcock I, Berger P, Bonniaud P, Chanson P, Chenivesse C . How can we minimise the use of regular oral corticosteroids in asthma?. Eur Respir Rev. 2020; 29(155). PMC: 9488989. DOI: 10.1183/16000617.0085-2019. View

19.

Rudmik L, Soler Z, Smith T, Mace J, Schlosser R, DeConde A . Effect of Continued Medical Therapy on Productivity Costs for Refractory Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2015; 141(11):969-73. DOI: 10.1001/jamaoto.2015.2321. View

20.

Snidvongs K, Pratt E, Chin D, Sacks R, Earls P, Harvey R . Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2012; 2(5):415-21. DOI: 10.1002/alr.21047. View